COVID-19: Vaccination update in Latin America
Argentina has administered more than 53,1 million doses to date, or more than 66,1% of the population of which more than 23.2 million are fully immunized throughout the country. From the week of June 8, 2021, it will be the first country on the continent to produce the Russian vaccine Sputnik at a rate of 500,000 doses per week in order to accelerate this vaccination process.
In Bolivia, 4.25 million people were able to benefit from the vaccination campaign, or more than 36,4% of the total population.
Brazil, which has been particularly affected by the pandemic, has been able to provide nearly 71,9% of its inhabitants (more than 152.8 million) with a first dose of vaccine and 95.3 million are now fully vaccinated.
In Chile, it has 81,5% of immunized children, of which more than 74,1% have received two doses. It is the most advanced Latin American country to date in its vaccination campaign.
Colombia for its part has begun the last phase of its plan which has 5. To date, 41,5 million doses have been administered to a total of more than 27 million people or 53.4% of the target population.
In Costa Rica, more than 66.9% of the population received a first injection and 43% the second, for a total of 3,4 million people.
In Ecuador, 56.2% of the population is immunized, for a total of 9,92 million people. The province of Galapagos for its part is fully vaccinated in order to allow the revival of tourism as quickly and safely as possible.
In Guatemala, 27.7% of the population has had access to the COVID-19 vaccine, or just over 4,676,499 people. The United States, through Vice President Kamala Harris, has announced the sending of half a million doses in order to speed up the vaccination process.
Mexico has 46.3 million supplements vaccinated, or 35.9% of its target population and 19.3% of first-time vaccinated. In the coming weeks the process will be intensified according to the government.
Nearly 2,938,275 inhabitants of Panama have received a first dose and 2,29 millions are fully vaccinated, or 49.2% of the population.
In Peru 36.1% of the population is vaccinated and more than 11.9 million others 4.4 milion have already received a first injection.
The disparities in the progress of each of the countries can be explained in particular by access to the stock of vaccines available for export to Latin America, since the region until now had no internal production. The situation should improve in the coming weeks with the production of Sputnik in Argentina and the announcement on June 9 of the President of the United States of the shipment of 500 million Pfizer vaccines to other countries on the continent.